Top Clicks This Month

9 10-DIMETHOXY-2-ANTHRACENESULFONIC ACI& - CAS 207233-92-9

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
Main Product
Product Name
9 10-DIMETHOXY-2-ANTHRACENESULFONIC ACI&
Catalog Number
207233-92-9
Synonyms
sodium;9,10-dimethoxyanthracene-2-sulfonate;hydrate;ST51007045;207233-92-9;9,10-Dimethoxy-2-anthracenesulfonicacidsodiumsaltmonohydrate
CAS Number
207233-92-9
Molecular Weight
358.34
Molecular Formula
C16H13NaO5SH2O
COA
Inquire
MSDS
Inquire
Canonical SMILES
COC1=C2C=CC(=CC2=C(C3=CC=CC=C31)OC)S(=O)(=O)[O-].O.[Na+]
InChI
InChI=1S/C16H14O5S.Na.H2O/c1-20-15-11-5-3-4-6-12(11)16(21-2)14-9-10(22(17,18)19)7-8-13(14)15;;/h3-9H,1-2H3,(H,17,18,19);;1H2/q;+1;/p-1
InChIKey
NGXAGKVEVBJNRP-UHFFFAOYSA-M
Structure
CAS 207233-92-9 9 10-DIMETHOXY-2-ANTHRACENESULFONIC ACI&
Specification
Purity
95%
Melting Point
>300ºC(lit.)
Reference Reading
1.Evaluating Joint Morbidity after Chondral Harvest for Autologous Chondrocyte Implantation (ACI): A Study of ACI-Treated Ankles and Hips with a Knee Chondral Harvest.
McCarthy HS1, Richardson JB2, Parker JC1, Roberts S1. Cartilage. 2016 Jan;7(1):7-15. doi: 10.1177/1947603515607963.
OBJECTIVE: To establish if harvesting cartilage to source chondrocytes for autologous chondrocyte implantation (ACI) results in donor site morbidity.
2.Clinical Decision Support and Palivizumab: A Means to Protect from Respiratory Syncytial Virus.
Utidjian LH1, Hogan A2, Michel J3, Localio AR4, Karavite D3, Song L5, Ramos MJ3, Fiks AG1, Lorch S2, Grundmeier RW1. Appl Clin Inform. 2015 Dec 30;6(4):769-84. doi: 10.4338/ACI-2015-08-RA-0096. eCollection 2015.
BACKGROUND AND OBJECTIVES: Palivizumab can reduce hospitalizations due to respiratory syncytial virus (RSV), but many eligible infants fail to receive the full 5-dose series. The efficacy of clinical decision support (CDS) in fostering palivizumab receipt has not been studied. We sought a comprehensive solution for identifying eligible patients and addressing barriers to palivizumab administration.
3.Gel-type autologous chondrocyte implantation for cartilage repair in patients with prior ACL reconstruction: A retrospective two year follow-up.
van Duijvenbode DC1, Jonkers FJ2, Könst YE3, van Royen BJ4, Benink RJ5, Hoozemans MJ6. Knee. 2016 Mar;23(2):241-5. doi: 10.1016/j.knee.2015.08.015. Epub 2016 Jan 28.
PURPOSE: To describe the early patient-reported outcomes of articular cartilage repair in patients with pain due to grade III or IV articular cartilage defects after prior anterior cruciate ligament (ACL) reconstruction.
4.Usability Evaluation of a Clinical Decision Support System for Geriatric ED Pain Treatment.
Genes N1, Kim MS2, Thum FL1, Rivera L1, Beato R1, Song C1, Soriano J3, Kannry J4, Baumlin K1, Hwang U5. Appl Clin Inform. 2016 Mar 9;7(1):128-42. doi: 10.4338/ACI-2015-08-RA-0108. eCollection 2016.
BACKGROUND: Older adults are at risk for inadequate emergency department (ED) pain care. Unrelieved acute pain is associated with poor outcomes. Clinical decision support systems (CDSS) hold promise to improve patient care, but CDSS quality varies widely, particularly when usability evaluation is not employed.
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE